Technology
Empowering every lab with next-generation biology tools.
A Toolkit of Reagents for Accelerating Discovery
We make interoperable tools for assembly, amplification, and expression—that plug into diverse workflows, from academic labs to industrial platforms.
Powered by synthetic biology and designed for reliability, our products help teams move concepts into results, quickly.
In partnership with top synthetic biology experts like Dan Gibson, we extend foundational innovations into tools scientists use every day.
Learn more about our applications
Scientific Achievements Made With Gibson Assembly®
2008
First Synthetic Genome
2009
Creation of Gibson Assembly®
2010
First Synthetic Life
2013
Synthetic Flu Vaccine
2016
First Minimal Genome
2017
Digital-to-Biological Conversion
At the J. Craig Venter Institute (JCVI), Dan Gibson and the JCVI team constructed the world’s first fully synthetic bacterial genome. In this landmark achievement, they assembled an entire Mycoplasma genome from scratch, proving that a complete organism’s DNA could be synthesized in the lab. This effort—essentially writing life’s code by hand—set the stage for all subsequent advances in synthetic biology.
Driven by the need to rapidly piece together large DNA molecules, Dan Gibson developed Gibson Assembly®, a one-step enzymatic process that allowed DNA fragments to be joined seamlessly in a single reaction. Introduced in 2009, it revolutionized genetic engineering by making it faster and easier to build genes and whole genomes, quickly becoming a standard tool in labs worldwide.
Building on these advances, JCVI researchers used Gibson Assembly® to create the first self-replicating synthetic cell. By assembling and activating the Mycoplasma mycoides genome inside a bacterial cell, they produced a new life form controlled entirely by designer DNA. This “synthetic life” milestone was a watershed moment, demonstrating that humans can not only read the code of life but also write it.
In 2013, joint efforts between JCVI and Synthetic Genomics applied Gibson Assembly® to vaccine development. The teams created one of the first synthetic influenza vaccines by synthesizing flu virus genes directly from digital sequence data. This rapid-response approach showed that vaccines could be generated in dramatically shorter timeframes, foreshadowing a future where emerging viral threats could be countered with speed and precision.
At JCVI and Synthetic Genomics, scientists used Gibson Assembly® to engineer the first minimal bacterial genome. Completed in 2016, this project stripped a cell’s genome down to just 473 genes—the bare essentials for life—answering fundamental questions about what genetic elements are necessary and pushing the boundaries of synthetic biology.
At Synthetic Genomics, Gibson Assembly® also supported the development of the digital-to-biological converter (DBC)—a prototype device capable of taking a digitized DNA sequence and producing biological molecules on demand. This concept of transmitting genetic designs electronically and “printing” them as DNA, RNA, or even vaccines anywhere in the world highlighted how synthetic biology could bridge the digital and biological domains, laying groundwork for on-demand biomanufacturing.
Development Roadmap
2025
F1-X™ Next-Gen Gibson Assembly
Early 2026
RC-X™ and V1-X™
Beyond
The Cell-Free Future
F1-X™ Next-Gen Gibson Assembly
F1-X™ advances the classic one-step Gibson Assembly® workflow with a Racer-engineered enzyme system that minimizes junction errors and extends multi-fragment capacity. Assemble multiple fragments seamlessly in a single tube while reducing total time to sequence-verified constructs. seamlessly in a single tube while reducing screens and total time to sequence-verified constructs. Designed for complex pathways, large inserts, and automation.
Pre-Order Now
V1-X™ – High Yield Microbial Protein Expression
Accelerate the path from idea to expression.
V1-X™ delivers microgram-scale, E. coli–free plasmid amplification—mix, incubate, done. Paired with F1-X™ Next-Gen Gibson Assembly, RC-X™ enables a digital-sequence-to-protein-expression workflow without E. coli. V1-X™ is a Vibrio natriegens–based expression system for high-yield production on short timelines. Together, they create faster routes to results.
Join Waitlist
The Cell-Free Future
We’re building cell-free systems that assemble and amplify DNA in a single tube at very low cost, with no cold chain. Fueled by low-cost substrates and metabolism-powered systems, just add DNA, incubate, and walk away with build-ready material. Freezer-free, automation-friendly, and built to make advanced cloning accessible to any lab.
Join WaitlistRacer Bio: Pioneering Synthetic Biology
Racer Bioscience’s innovation is guided by one of synthetic biology’s true pioneers: Dr. Dan Gibson. He is renowned for creating the groundbreaking Gibson Assembly® method – a revolutionary DNA assembly technique that seamlessly joins genetic fragments – and for spearheading unprecedented feats in synthetic genome engineering. From building the first synthetic genome to creating the first synthetic life form, Dr. Gibson’s work has continually pushed the boundaries of molecular innovation. His visionary leadership in synthetic biology provides the foundation for Racer’s technology roadmap, marrying a legacy of breakthroughs with a future-focused mission.
Shaping the Next Generation of Tools
Design tools for modular, scalable synthetic biology pipelines
Develop reagents that are plug-and-play compatible with common workflows
Drive speed, accuracy, and reproducibility for modern molecular biology
Shaping the Next Generation of Tools
"From inventing Gibson Assembly® to shaping the tools of tomorrow, my mission has always been to push the boundaries of what’s possible in molecular biology. At Racer Bioscience, we’re building the next generation of DNA technologies—faster, smarter, and ready for discoveries the world hasn’t imagined yet."
A growing portfolio of next-generation molecular biology reagents.
Join our Waitlist- Choosing a selection results in a full page refresh.